Nanox climbs as AI software improves detection of risk factor for bone disease
** U.S.-listed shares of Israel-based medtech co Nano-X
Imaging NNOX.O rise ~3.1% to $9.67 premarket
** Co says its AI solution, HealthVCF, when evaluated in a
study, identified up to six times more patients with vertebral
compression fracture (VCF) than the national average in the UK
** VCF is a strong risk factor for osteoporosis, a disease
which causes the bones to become weak and brittle
** Up to last close, stock up 42.3% in the last 12 months
(Reporting by Christy Santhosh)
((Christy.Santhosh@thomsonreuters.com))
Recent news on Nano-X Imaging
See all newsBrief: Nano-X Imaging Ltd CFO Guy Nathansohn Resigns On Oct 26, Citing Medical Reasons - SEC Filing
Nano-X Imaging Q3 revenue grows on AI solutions; flags going concern issues
Nano-X Imaging Ltd reports results for the quarter ended June 30 - Earnings Summary
Israel's Nano-X Imaging Q2 revenue misses estimates
Nano-X Imaging Ltd expected to post a loss of 16 cents a share - Earnings Preview